
Nokia Corp. (NYSE: NOK) was added to the U.S. and EU Focus Lists at Credit Suisse. The firm’s target price in euros implies 23% upside, and it was called a new equity story emerging around robust bottom-line growth and margin expansion, supported by material cash distribution ahead.
Safeway Inc. (NYSE: SWY) is being acquired for $40 per share after closing at $39.47. So far we have seen the grocery chain raised to Neutral from Sell at UBS, and shares were downgraded to Hold from Buy at BB&T.
Sirius XM Holdings Inc. (NASDAQ: SIRI) closed at $3.55 and is still under its supposed buyout price. Macquarie has raised the rating to Outperform from Neutral and believes that Sirius is worth $4 per share, versus a prior $3.75 price target. The firm believes that the minority shareholders are now in a better bargaining position, and it sees growth ahead in the next three-year period.
Skullcandy Inc. (NASDAQ: SKUL) is trading up more than 20% after strong earnings and guidance. A firm called Northland Securities has raised its rating to Outperform, looking for even more upside. Be advised that the consensus price target was less than $6 before the news, and the stock already closed at $7.43 and was indicated up above $9 in the premarket.
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) was raised to Overweight from Equal Weight at Barclays. The big jump is in the Barclays price target — up to $65 from $42 (versus a $49.82 closing price).
Other Key Analyst Calls
Alpha Natural Resources Inc. (NYSE: ANR) was downgraded to Sell from an already cautious Neutral rating at Goldman Sachs.
Boulder Brands Inc. (NASDAQ: BDBD) was reiterated as Buy with a $17.50 price target and called a growth platform that is still underappreciated by Canaccord Genuity.
Copa Holdings S.A. (NYSE: CPA) was raised to Buy from Neutral at UBS.
GT Advanced Technologies Inc. (NASDAQ: GTAT) was raised to Outperform from Neutral at Credit Suisse, and the price target was raised to $24 from $18 (versus a $16.98 close) based mostly on nearing commercialization of new products.
Humana Inc. (NYSE: HUM) was downgraded to Hold from Buy at Jefferies.
Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) was started as Overweight at Barclays.
Polycom Inc. (NASDAQ: PLCM) was raised to Buy from Neutral by Citigroup.
The Fresh Market Inc. (NASDAQ: TFM) was raised to Buy from Neutral at UBS; Sterne Agee reiterated its Neutral rating and lowered its price target to $35.
Staples Inc. (NASDAQ: SPLS) was downgraded to Hold from Buy, after a huge earnings disappointment, at Argus.